Products

Our products

Learn more about our product portfolio and how we’re prioritising specialty medicines and vaccines to get ahead of disease together.

Our product areas Products A-Z

Close Video

Scroll to explore

Our product areas

Specialty medicines

Specialty medicines are prescribed by specialist healthcare practitioners. Our portfolio of specialty medicines prevents and treats diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer.

Vaccines

Our portfolio of more than 20 marketed vaccines is one of the broadest in the industry. We deliver more than 1 million doses of our vaccines every day. Our vaccines portfolio targets infectious diseases from birth throughout adulthood.

Escherichia Coli (E. Coli) Bacteria Science Image

General medicines

General medicines are usually prescribed in primary care or community settings by general healthcare practitioners. General medicines include inhalers for asthma and COPD to antibiotics. Every day, our general medicines make life better for millions of people all over the world.

View our product areas

Our medicines and vaccines

Getting ahead means preventing disease as well as treating it. Our R&D focus is to deliver new medicines and vaccines using the science of the immune system and advanced technologies to impact health at scale.

Medicine and vaccine manufacturing sites in our global network

1.7bn

Packs of medicines delivered in 2024

409m

Vaccine doses delivered in 2024

20+

Our vaccines target diseases from birth through adulthood.

Explore our innovation stories

Innovation is at the very core of GSK. Discover how we’re uniting science, technology and talent to get ahead of disease together.

‘The roar I hear is the next stage of the rocket firing’: MAPS technology and the new age of vaccine development

‘It’s insidious and it’s getting worse’: AMR and the urgent need for novel antibiotics

Scientists gain ground in centuries-long malaria struggle – but more innovation is needed to stay ahead of evolving parasites

Modern technologies are doubling the odds of scientists making life-changing medical discoveries

Age-related decline in immunity: why does it matter and what can be done about it?

Vaccinations are not just for children: why adult immunisation is a health and economic necessity

‘We’re not a world of men – it's as simple as that’: how gender diversity in clinical trials improves health outcomes for women

Read our magazine

Continue to Responsibility